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[Abstract] An important component of this methodology is to assess the role of the tumor 
microenvironment on tumor growth and survival. To tackle this problem, we have adapted the 
original approach of Warburg (Warburg, 1923), by combining thin tissue slices with Stable 
Isotope Resolved Metabolomics (SIRM) to determine detailed metabolic activity of human 
tissues. SIRM enables the tracing of metabolic transformations of source molecules such as 
glucose or glutamine over defined time periods, and is a requirement for detailed pathway 
tracing and flux analysis. In our approach, we maintain freshly resected tissue slices (both 
cancerous and non- cancerous from the same organ of the same subject) in cell culture media, 






N2-glutamine. These slices are viable for at least 24 h, and make it possible to eliminate 
systemic influence on the target tissue metabolism while maintaining the original 3D cellular 
architecture. It is therefore an excellent pre-clinical platform for assessing the effect of 
therapeutic agents on target tissue metabolism and their therapeutic efficacy on individual 
patients (Xie et al., 2014; Sellers et al., 2015).   
 
Materials and Reagents 
 
1. 25 ml T Flasks NC vent cap (SARSTEDT AG & Co, catalog number: 83.1810.002)  
2. Portable container for liquid nitrogen (Nalgene plastic dewar) (Thermo Fisher Scientific, 
catalog number: S34074C) 
3. Sterile syringes and needles (Thermo Fisher Scientific, catalog number: 10142534) 
4. Disposable transfer pipets (Samco fine tip, 1 ml) (VWR International, catalog number: 
16001192) 
5. Aerosol barrier tips for 1 ml and 1-200 μl (Thermo Fisher Scientific, catalog number: 
02-707-42) 
6. Screw cap plastic vials (2 ml) color coded caps (yellow, blue, green and red) (USA 
Scientific, catalog number: 1420-8706, 1420-8701, 1420-8702 and 1420-9704) 
7. Snap top plastic vials (1.5 ml) (USA Scientific, catalog number: 1615-5510) 
8. 15 ml Falcon tubes (SARSTEDT AG & Co, catalog number: 62.554.205)  
9. Dialyzed, sterile filtered fetal bovine serum (FBS) (free of serum metabolites),10-12 
kDa (Atlanta Biochemical, catalog number: S12650) 

















C], 99%) (Cambridge Isotope Laboratories, 
catalog number: CLM-1396-CTM), 
13
C2-1, 2 glucose/D-glucose (1, 2-
13
C2, 99%) 









N2, 99%) (Cambridge Isotope Laboratories, catalog number: 
CNLM-1275)  or 
Isotec: D-
13
C6-glucose (Sigma-Aldrich, catalog number: 660663), 
13
C2-1, 2 glucose 





catalog number: 607983)  
12. Penicillin + Streptomycin: GE Healthcare PEN/STREP/FUNGIZONE 100 ml (Thermo 
Fisher Scientific, catalog number: SV3007901) 
13. Protocol
TM
 10% Neutral buffered formalin (Thermo Fisher Scientific, catalog number: 
032-059) 
14. 25% (w/v) sterile filtered 
13C glucose (0.2 μm) in PBS (Stock solution-can be frozen, 
aliquoted, and stored at 4 °C) 
15. Liquid nitrogen 
16. 70% ethanol (v/v) 
17. 60% acetonitrile in water (v/v) (Sigma-Aldrich, catalog number: L010400) 
18. Sodium chloride (NaCl) (Thermo Fisher Scientific, catalog number: S271-1) 
19. Potassium chloride (KCl) (Sigma-Aldrich, catalog number: P9541) 
20. Sodium phosphate dibasic (Na2HPO4) (Sigma-Aldrich, catalog number: S0876) 
21. Potassium phosphate monobasic (KH2PO4) (Sigma-Aldrich, catalog number: P9791) 
22. Amino acids: Glycine, L-Arginine, L-Asparagine, L-Aspartic acid, L-Cystine 2HCl, 
L-Glutamic Acid, L-Glutamine, L-Histidine, L-Hydroxyproline, L-Isoleucine, L-Leucine, 
L-Lysine hydrochloride, L-Methionine, L-Phenylalanine, L-Proline, L-Serine, 
L-Threonine, L-Tryptophan, L-Tyrosine disodium salt dehydrate, L-Valine 
23. Vitamins: Biotin, Choline chloride, D-Calcium pantothenate, Folic Acid, i-Inositol, 
Niacinamide, Para-Aminobenzoic Acid, Pyridoxine hydrochloride, Riboflavin, Thiamine 
hydrochloride, Vitamin B12 
24. Calcium nitrate [Ca(NO3)2
.
4H2O] 
25. Magnesium sulfate (MgSO4)  
26. Glutathione (reduced) 
27. Phenol Red 
28. Relevant medium (e.g. DMEM, RPMI, other defined medium) which lacks the tracer of 
interest: 
a. Dulbecco′s Modified Eagle′s Medium (DMEM) is a powder formula, free of glucose, 
glutamine, pyruvate bicarbonate, and phenol red, giving considerable flexibility in 
formulation for SIRM studies (Sigma-Aldrich, catalog number: D5030) (see 
Recipes) 




b. RPMI 1640 is a liquid medium free of glucose and glutamine, but contains 
bicarbonate and phenol red (MP Biomedicals, catalog number: 091646854) (see 
Recipes) 
29. 0.2 µm sterile filtered Phosphate Buffered Saline (PBS) (see Recipes) 
30. Medium composition for 0.2% 
13
C6-glucose, 2 mM 
12
C-Gln (100 ml) (see Recipes) 
31. Medium composition for 0.2% 
12








1. Class II Biosafety Hood 
2. Trigas incubator with oxygen sensor and CO2 sensor (Thermo Fisher Scientific, model: 
Hera cell 150i) 
3. Sterilized rocker (Rotoshake Genie) (Scientific Industries, model: SI-1100) 
4. Liquid nitrogen freezer for storage 
5. K2-EDTA vacutainers (“purple top”) (BD, catalog number: 366643) 
6. Refrigerated centrifuge with swing out rotor that can accept vacutainers [e.g. Sorvall 
Legend X1R (Thermo Fisher Scientific, catalog number: 75-004-261) with a rotor 
(Thermo Fisher Scientific, catalog number: 75003181)] 
7. Pipettors (variable size ranges) (USA Scientific ErgoOne) 
8. Weck Knife/Dermatome (George Tiemann & Co., catalog number: 222-5-523) 
9. Weigh boats (Thermo Fisher Scientific, catalog number: 08732113 and 08732115) 
10. 4-place balance (Thermo Fisher Scientific, Mettler-Toledo, catalog number: 0133525) 
11. Ice bucket (Thermo Fisher Scientific, catalog number: 02-591-44) 
12. Sharp dissecting scissors (Thermo Fisher Scientific, catalog number: 08940) 
13. Excelta™ Plastic Tweezers (Thermo Fisher Scientific, catalog number: 17-456-066) 




A. Tissue procurement 
All tissue must be procured under an IRB approved protocol. As live human tissue is 
handled, all personnel must undergo and maintain biosafety, HIPAA and CITI certifications.  











Scheme 1. FlowChart. Preop: Preoperative room; OR: Operating Room. The number of 
thin slices to be taken depends on the size of the tumor. A piece of tissue is also flash 
frozen in the OR, and additional tissue is placed in formalin for pathological analysis. 
 
1. Blood samples provide overall information about the metabolic status of the individual 
subjects, and the buffy coat can be used for extracting DNA or RNA for sequence 
analysis. 
2. A 10 ml sample of blood should be drawn preoperatively into a purple top vacutainer 
(K2-EDTA) preoperatively. Other anticoagulants such as citrate or heparin should not 
be used as they interfere with metabolic assays. A blood sample should also be drawn 
perioperatively after resection. The blood is inverted twice to ensure dissolution of the 
EDTA, and kept on ice immediately after blood draw. The blood should be separated 
into packed red cells, buffy coat and plasma within 30 min by centrifuging at 3,500 x g 
for 15 min at 4 °C in a swing out rotor. 
Subsequent operations should be carried out in a BSL2
+
 biosafety cabinet. 
Note: We use the following color codes for storage: Red = whole blood, yellow = 
plasma, green = buffy coat, blue = urine. 
3. Plasma is aspirated into prechilled sterile 2 ml screw cap vials at 1 ml aliquots and flash 




frozen in liquid N2. Buffy coat is aspirated using a wide mouth plastic pipette into a 2 ml 
screwcap vial and flash frozen in liquid N2.  
4. These experiments have been carried out on fresh slices of paired cancerous (CA) and 
non-cancerous (NC) lung tissues resected from non-small cell lung cancer (Xie et al., 
2014) and pancreatic cancer patients. Upon resection, thin slices (0.5-1 mm thick) of 
tissue are excised from the surface of visually non-necrotic or fibrotic tumor regions 
using a Weck microtome in the Operating Room (OR), within approximately 5-10 min of 
resection. Roughly 1 cm
2
 tissue is targeted (see Figure 1A). Control non-cancerous 
tissue from a distant (>10 cm) region is obtained similarly. A pathologist on-site 
inspects the CA and NC tissue specimens. Highly necrotic tissue is discarded. 
5. At the same time, a small piece of bulk CA tissue should be placed in DMEM or other 
appropriate medium kept room temperature for implantation into a recipient NSG 
mouse as patient-derived xenograft or PDX. A small piece each of CA and NC tissues 
is soaked in formalin for pathological examination or flash frozen in liquid N2 for 
image-based metabolic analysis.  
6. Where tissue acquisition in the OR is impractical (such as colorectal or breast cancer 
resections), the slices can be prepared in the pathology laboratory located close to the 
OR. For comparison with freshly resected tissue, speed is essential as metabolism is 
rapidly changing. Whenever feasible, tissue freezing should be performed in the OR. 
7. The slices are placed into a drop of sterile PBS on two sterilized weigh boats to prevent 
sticking and for spreading slices evenly. Each weight boat is pre-numbered for CA or 
NC slices. The tissues on weight boats are then photographed. Each slice is rinsed 
briefly with sterile PBS, blotted (twice) and then carefully placed into pre-numbered 
(using ethanol-resistant marker pen) pre-tared (tare weight recorded) T25-flasks 
containing 10 ml DMEM (or other relevant medium) with the appropriate tracer (e.g. 10 
mM 
13




N2-glutamine), 10% dialyzed FBS (as needed), and 
1x penicillin + streptomycin. The flasks with slices are brought to the culture room as 
soon as possible and sprayed with 70% ethanol, and wiped dry before placing them in 
the Biosafety hood.   
8. Pipet 200 μl culture media from each flask into 1.5 ml snap-cap tubes (t0-time zero 
media samples). Centrifuge for 10 min at 10,000 x g at 4 °C to remove tissue debris. 
Transfer 100 μl to tared 1.5 μl snap-cap tube for metabolite extraction and weigh the 
media transferred. Transfer the remaining media to a 1.5 ml screw-cap tube for 
long-term storage at -80 °C. 
9. Weigh flasks in a 2-place balance inside the Biosafety hood and record weight on the 
flask.  
10. Transfer flasks to a CO2 incubator containing a rocker set to low amplitude rocking 
(sufficient to ensure that the liquid moves over the slices without non-laminar flow) 
Figure 1B) set to 37 °C and 5% CO2, with oxygen set to the desired level (e.g. 20%, 
1%). 




11. The flasks are continuously and gently rocked for 24 to 48 h for gas exchange and to 
maintain constant nutrient supplies at the tissue surface, while avoiding local buildup of 
waste products such as acids.  
12. As needed, the medium can be refreshed every 12 h, and sampled at 0, 6, 12, 24…. h 
for analysis of nutrient uptake and waste production. The flasks are weighed before 
and after each medium sampling point and flask weights are recorded on the flasks.  
 
B. Tissue Harvesting 
1. After 24 h incubation, weigh flasks.  
2. Place flasks on ice immediately after removing from the incubator to minimize further 
metabolism. Up to 6 flasks can be harvested at a time. Keep tissue slices on ice as 
much as possible during harvest. 
3. Using a transfer pipet, aspirate and transfer the conditioned media into 15-ml conical 
centrifuge tubes. 
4. Centrifuge media for 15 min at 3,500 to 4,690 x g, 4 °C to remove any particulates and 
debris. 
5. Pipet 100 μl T24 media supernatant into 1.5-ml snap-cap tubes for metabolite 
extraction. 
6. Pipet 1 ml media aliquot into 2-ml screw-cap tubes for long-term storage at -80 °C. 
7. The remaining medium is stored separately in a 7 ml vial at -80 °C for purposes such as 
exosome isolation. 
8. Invert and tap the flask to move the tissue slices into the cap or neck region of the flask 
for retrieval. Keep flask inverted on ice. 
9. Wash tissue slices 3x consecutively in ice-cold 10 ml cold PBS each in a 50 ml beaker.   
10. Blot dry the tissue slices on Kimwipe and photograph the flattened slice on a small 
weigh boat. 
11. Weigh the whole tissue slice on small weigh boats and record the weight.  
12. Split a very small piece for preservation in 1 ml buffered formalin in a 1.5 ml snap-cap 
tube for histology. The remaining tissue slice is split evenly and each piece should 
weigh no more than 20-30 mg by wet weight to facilitate tissue homogenization and 
extraction efficiency. Immediately after weighing, each piece is flash-frozen in liq. N2 
and placed in a pre-liq. N2 chilled 1.5-ml snap-cap tube for long-term storage at -80 °C.  
13. After 6-8 h in formalin, replace the formalin with 70% ethanol for the tissue pieces 
prepared for histology. 
14. Homogenize tissues in cold 60% acetonitrile (v/v) and extract tissue homogenates for 
metabolite analyses according to standardized protocols (Fan, 2012; Fan, 2010) before 
analyses using stable isotope-resolving analytical techniques (e.g. NMR and MS) (Fan, 
2012) (Figure 1C) (Lane et al., 2008). 
15. This Protocol describes the procedure for stable isotope labeling of thin tissue slices.  
SIRM analysis involves the quantification of isotopomers (by NMR) and isotopologues 











N Glutamine) in cells or tissue (Figure 1C). The techniques of SIRM analysis 
by NMR and mass spectrometry are described in detail in Sellers et al. (2015); Lane et 
al. (2008) and Fan et al. (2012).  
 
Representative data  
 
A                                 B 
 
C      Ex vivo tissue slices 
 
Figure 1 Example ex vivo tissue slice experiment. A. Example thin slices of 
non-cancerous lung tissue (NC, left) adjacent to a lung adenocarcinoma (CA, right); B. 




C} HSQC NMR 
spectra (recorded at 14.1 T, 15 °C) of extracts of CA versus NC lung slices from an non 
small cell lung cancer (NSCLC) patient incubated for 24 h in the presence of 10 mM 
13
C6-glucose. The tissue slices were pulverized and extracted as described (Sellers et al., 
2015; Fan, 2012) which produces three phases- an upper aqueous phase containing polar 
metabolites, a lower organic phase containing non-polar metabolites (mainly lipids) and an 
interfacial phase that contains protein. Here the upper phase was lyophilized and 
redissolved in a phosphate buffer containing 50% D2O and 25 nmol DSS-d6 that serves 
both as a chemical shift reference and a concentration standard (Fan and Lane, 2013). The 
HSQC spectrum detects protons attached directly to 
13
C, and thus gives a readout of the 
metabolites that have incorporated 
13
C from the source molecule (glucose in this instance). 
The spectra of cancer and non-cancerous tissues are recorded under identical conditions, 




and the absolute intensities are normalized to the tissue protein weight. Peak areas were 
determined using peak fitting functions in MNOVA (Mestrelab Research, Santiago de 
Compostela, Spain) 
Enhanced production of various 
13
C labeled metabolites in the CA tissue slice is evident, 
including 
13
C-lactate (Lac), which is consistent with the Warburg effect or accelerated 




1. These procedures have been tested on freshly resected NSCLC and pancreatic 
cancer, as well as in patient derived mouse xenografts. Other tissues may need 
experimentation with the composition of the medium and length of incubation period for 
metabolic viability. 
2. Larger or inflammatory tumors may have substantial areas of necrosis or fibrosis that 
need to be avoided.   
3. A Weck microtome is hand held, but with practice the surgeons can reproducibly 
produce slices < 1 mm thick. Slice thickness is easily estimated by measuring the area 
of the slice from a photograph and from the wet weigh as the average thickness h = 
weight/area. 
4. Some tumors are highly mucilaginous and are more difficult to slice reproducibly. 
5. An alternative to a Weck microtome is a vibrating microtome, which can reproducibly 
generate thinner slices from firm but not soft tissues (cf
10
), but is much slower. Very thin 
slices (100-200 μm) may show a proportionately larger wounding response and are 
more fragile. 
6. As many tumors are heterogeneous not only in the cancer/stromal content in different 
regions of the tumor but also in terms of genetics, it is advisable to obtain multiple slices 
from the tumor to cover this heterogeneity. This also makes histopathological 
examination of each slice critically important. 
7. The margins of some tumors are not obvious without pathological examination.  





1. DMEM and RPMI Medium 1640   
For SIRM studies, the glutamine or glucose free version of the medium should be used, 
with supplementation of the appropriate concentration of 
13
C-enriched precursors in the 
base medium. 
 













Amino Acids  
Glycine 75 10 0.133            0.40             
L-Arginine 174 200 1.15 0.483 
L-Asparagine 132 50 0.379 - 
L-Aspartic acid 133 20 0.150 - 
L-Cystine 2HCl 313 65 0.208 0/0.2 
L-Glutamic Acid 147 20 0.136 - 
L-Glutamine 146 300 2.05 2 
L-Histidine 155 15 0.0968 0.27 
L-Hydroxyproline 131 20 0.153 - 
L-Isoleucine 131 50 0.382 0.8 
L-Leucine 131 50 0.382 0.8 
L-Lysine hydrochloride 146 40 0.274 1.0 
L-Methionine 149 15 0.101 0.2 
L-Phenylalanine 165 15 0.0909 0.4 
L-Proline 115 20 0.174 - 
L-Serine 105 30 0.286 0.4 
L-Threonine 119 20 0.168 0.8 
L-Tryptophan 204 5 0.0245 0.078 
L-Tyrosine disodium salt 
dihydrate 
261 29 0.111 0.4 
L-Valine 117 20 0.171 0.8 
Vitamins  
Biotin 244 0.2 0.000820  
Choline chloride 140 3 0.0214 0.0285 
D-Calcium pantothenate 477 0.25 0.000524 0.008 
Folic Acid 441 1 0.00227 0.009 
i-Inositol 180 35 0.194 .04 




Niacinamide 122 1 0.00820 0.033 
Para-Aminobenzoic Acid 137 1 0.00730  
Pyridoxine hydrochloride 206 1 0.00485 .019 
Riboflavin 376 0.2 0.000532 .001 
Thiamine hydrochloride 337 1 0.00297 .012 
Vitamin B12 1,355 0.005 0.0000037 - 





236 100 0.424  
Magnesium Sulfate 
(MgSO4) (anhyd.) 
120 48.84 0.407  
Potassium Chloride (KCl) 75 400 5.33  
Sodium Bicarbonate 
(NaHCO3) 
84 2,000 23.81 44 
Sodium Chloride (NaCl) 58 6,000 103.45  




268 1,512 5.64  
Other Components  
Glutathione (reduced) 307 1 0.00326  
Phenol Red 376.4 5 0.0133  
 
2. 10x PBS 
Sources of reagents are given in the Materials Section 
80 g NaCl  
2 g KCl  
14.4 g Na2HPO4 anhydrous 
2.4 g KH2PO4 anhydrous 
Dissolve in 950 ml 18 MOhm water, pH to 7.4, make to 1 L, sterile filter (0.2 μm) 
3. Medium composition for 0.2% 
13
C6-glucose, 2 mM 
12
C-Gln (100 ml) 
89.2 ml base medium minus tracer (e.g. glucose-free version) (89% concentration of 
nutrients) 
10 ml sterile filtered dialyzed FBS (10% FBS) 
0.8 ml 25% sterile filtered 
13
C6 glucose (0.2 µm) in PBS (10.75 mM glucose final) 
1 ml 100x streptomycin/penicillin stock 
4. Medium composition for 0.2% 
12




N2-Gln (100 ml) 




88 ml base medium minus tracer (glutamine-free version) (88% concentration of all 
nutrients) 
10 ml sterile filtered dialyzed FBS (10% FBS) 




N2-glutamine (0.2 µm) in PBS (2 mM final) 
1 ml 100x streptomycin/penicillin stock 
For hormone sensitive tissues, activated carbon-stripped FBS may be used.  
For other concentrations of FBS, adjust the volumes of the FBS and base medium 
accordingly. 
Note: Glutamine stock should be made fresh or stored at -20 °C in small aliquots to 
avoid repeated freeze and thawing. It forms pyroglutamate on storage in solution even 
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